Previous Blogs

Blue West logo with Diamond

By Tibor Hlobik

November 12, 2013

Cartridge-based administration using injection device systems has dominated the insulin market for many years. In 2011, the insulin market for cartridge-based container closure systems was at an estimated 1 billion units. Additional applications for cartridge-based container systems include dental, at more than 450 million units per year, and therapies such as human growth hormone, interferon and epinephrine. In fact, thanks to lower production costs when compared to vial and syringe systems, cartridge-based delivery has found a widespread and growing market.

Blue West logo with Diamond

By Graham Reynolds

September 25, 2013

Most hand-held injectors today are designed for standard drug containers, such as prefilled syringes or cartridges. The primary markets include treatments for chronic conditions such as diabetes and hormone deficiencies where repeat injections are necessary and are administered by the patient or a caregiver.

Blue West logo with Diamond

By Joanne Neizer

August 26, 2013

As advancements in pharmaceutical technology increase in the use of automated injection systems for health care treatment, traditional glass vials, syringes and cartridges must withstand higher automated delivery forces and pressures. The fragile nature and dimensional variability in wall thickness of glass components may lead to breakage, which presents challenges to automatic administration systems.